Revance Therapeutics (NASDAQ:RVNC) Coverage Initiated at StockNews.com
Research analysts at StockNews.com began coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Get Free Report) in a report issued on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. A number of other research analysts have also commented on the stock. Piper Sandler lowered shares of Revance Therapeutics from a “strong-buy” […]
More Stories
Maverix Metals (CVE:MMX) Trading 4.7% Higher – What’s Next?
Maverix Metals Inc (CVE:MMX – Get Free Report)’s share price was up 4.7% during trading on Thursday . The company...
Uniserve Communications (CVE:USS) Trading Up 14.3% – What’s Next?
Shares of Uniserve Communications Co. (CVE:USS – Get Free Report) rose 14.3% during mid-day trading on Thursday . The stock...
WisdomTree Emerging Markets High Dividend Fund (NYSEARCA:DEM) Stock Price Down 0.3% – Here’s What Happened
WisdomTree Emerging Markets High Dividend Fund (NYSEARCA:DEM – Get Free Report)’s share price fell 0.3% during trading on Thursday ....
Reserve Petroleum (OTCMKTS:RSRV) Stock Price Down 6.2% – What’s Next?
The Reserve Petroleum Company (OTCMKTS:RSRV – Get Free Report) traded down 6.2% during mid-day trading on Thursday . The company...
Keystone Law Group (LON:KEYS) Stock Price Down 1.8% – Here’s Why
Keystone Law Group plc (LON:KEYS – Get Free Report)’s share price dropped 1.8% during trading on Thursday . The stock...
GreenPower Motor (CVE:GPV) Stock Price Up 38.1% – Still a Buy?
GreenPower Motor Company Inc. (CVE:GPV – Get Free Report) traded up 38.1% during mid-day trading on Saturday . The stock...